Oxford Diagnostic Laboratories (ODL™), located in Abingdon, Oxfordshire, is a trading division of Oxford Immunotec Limited, a Revvity company and processes over 400 TB samples daily with an impressive indeterminate result rate of less than 2%¹ - even when testing challenging patient populations. 

In this exclusive case study, learn how:

• The T-SPOT.TB test delivers reliable results for immunosuppressed and BCG-vaccinated patients
• The Auto-Pure 2400 automated platform has significantly improved their testing workflow
• The new automation has achieved 100% result concordance

"The implementation of the Auto-Pure 2400 with the T-SPOT.TB test has already yielded some exciting results, with zero occurrences of low PBMC rates and 100% result concordance across testing."
- Elliot Derby, Technical Scientist at ODL
 

Complete the form below to access the full case study and discover how your laboratory can achieve similar results.

For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.

1. Oxford Diagnostic Laboratories, data on file from 2014 - 2024. Cited on 14 February 2025.